Cancer Research Cancer Epigenetics  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stallings, R. L.
Right arrow Articles by Breatnach, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stallings, R. L.
Right arrow Articles by Breatnach, F.
[Cancer Research 66, 3673-3680, April 1, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

High-Resolution Analysis of Chromosomal Breakpoints and Genomic Instability Identifies PTPRD as a Candidate Tumor Suppressor Gene in Neuroblastoma

Raymond L. Stallings1, Prakash Nair1, John M. Maris2, Daniel Catchpoole3, Michael McDermott4, Anne O'Meara5 and Fin Breatnach5

1 Children's Cancer Research Institute and Department of Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, Texas; 2 Division of Oncology, Children's Hospital of Philadelphia and Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; 3 The Tumor Bank, Children's Hospital at Westmead, Sydney, New South Wales, Australia; and Departments of 4 Pathology and 5 Oncology, Our Lady's Hospital for Sick Children, Dublin, Ireland

Requests for reprints: Raymond L. Stallings, Children's Cancer Research Institute and Department of Pediatrics, University of Texas Health Science Center at San Antonio, 8403 Floyd Curl Drive, Mail Code 7784, San Antonio, TX 78229-3900. Phone: 210-562-9028; Fax: 210-562-9014; E-mail: Stallings{at}uthscsa.edu.

Although neuroblastoma is characterized by numerous recurrent, large-scale chromosomal imbalances, the genes targeted by such imbalances have remained elusive. We have applied whole-genome oligonucleotide array comparative genomic hybridization (median probe spacing 6 kb) to 56 neuroblastoma tumors and cell lines to identify genes involved with disease pathogenesis. This set of tumors was selected for having either 11q loss or MYCN amplification, abnormalities that define the two most common genetic subtypes of metastatic neuroblastoma. Our analyses have permitted us to map large-scale chromosomal imbalances and high-level amplifications at exon-level resolution and to identify novel microdeletions and duplications. Chromosomal breakpoints (n = 467) generating imbalances >2 Mb were mapped to intervals ranging between 6 and 50 kb in size, providing substantial information on each abnormality. For example, breakpoints leading to large-scale hemizygous loss of chromosome 11q were highly clustered and preferentially associated with segmental duplications. High-level amplifications of MYCN were extremely complex, often resulting in a series of discontinuous regions of amplification. Imbalances (n = 540) <2 Mb long were also detected. Although the majority (78%) of these imbalances mapped to segmentally duplicated regions and primarily reflect constitutional copy number polymorphisms, many subtle imbalances were detected that are likely somatically acquired alterations and include genes involved with tumorigenesis, apoptosis, or neural cell differentiation. The most frequent microdeletion involved the PTPRD locus, indicating a possible tumor suppressor function for this gene. (Cancer Res 2006; 66(7): 3673-80)




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
H.-Y. Huang, S.-H. Li, S.-C. Yu, F.-F. Chou, C.-C. Tzeng, T.-H. Hu, Y.-H. Uen, Y.-F. Tian, Y.-H. Wang, F.-M. Fang, et al.
Homozygous Deletion of MTAP Gene as a Poor Prognosticator in Gastrointestinal Stromal Tumors
Clin. Cancer Res., November 15, 2009; 15(22): 6963 - 6972.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Veeriah, C. Brennan, S. Meng, B. Singh, J. A. Fagin, D. B. Solit, P. B. Paty, D. Rohle, I. Vivanco, J. Chmielecki, et al.
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers
PNAS, June 9, 2009; 106(23): 9435 - 9440.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Bea, I. Salaverria, L. Armengol, M. Pinyol, V. Fernandez, E. M. Hartmann, P. Jares, V. Amador, L. Hernandez, A. Navarro, et al.
Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling
Blood, March 26, 2009; 113(13): 3059 - 3069.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
I. Janoueix-Lerosey, G. Schleiermacher, E. Michels, V. Mosseri, A. Ribeiro, D. Lequin, J. Vermeulen, J. Couturier, M. Peuchmaur, A. Valent, et al.
Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
J. Clin. Oncol., March 1, 2009; 27(7): 1026 - 1033.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. A. Solomon, J.-S. Kim, J. C. Cronin, Z. Sibenaller, T. Ryken, S. A. Rosenberg, H. Ressom, W. Jean, D. Bigner, H. Yan, et al.
Mutational Inactivation of PTPRD in Glioblastoma Multiforme and Malignant Melanoma
Cancer Res., December 15, 2008; 68(24): 10300 - 10306.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Greshock, J. Cheng, D. Rusnak, A. M. Martin, R. Wooster, T. Gilmer, K. Lee, B. L. Weber, and T. Zaks
Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines
Mol. Cancer Ther., April 1, 2008; 7(4): 935 - 943.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Stock, E. Bozsaky, F. Watzinger, U. Poetschger, L. Orel, T. Lion, A. Kowalska, and P. F. Ambros
Genes Proximal and Distal to MYCN Are Highly Expressed in Human Neuroblastoma as Visualized by Comparative Expressed Sequence Hybridization
Am. J. Pathol., January 1, 2008; 172(1): 203 - 214.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
J. S. Maydan, S. Flibotte, M. L. Edgley, J. Lau, R. R. Selzer, T. A. Richmond, N. J. Pofahl, J. H. Thomas, and D. G. Moerman
Efficient high-resolution deletion discovery in Caenorhabditis elegans by array comparative genomic hybridization
Genome Res., March 1, 2007; 17(3): 337 - 347.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Chen and R. L. Stallings
Differential Patterns of MicroRNA Expression in Neuroblastoma Are Correlated with Prognosis, Differentiation, and Apoptosis
Cancer Res., February 1, 2007; 67(3): 976 - 983.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
S M Gribble, D Kalaitzopoulos, D C Burford, E Prigmore, R R Selzer, B L Ng, N S W Matthews, K M Porter, R Curley, S J Lindsay, et al.
Ultra-high resolution array painting facilitates breakpoint sequencing
J. Med. Genet., January 1, 2007; 44(1): 51 - 58.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.